- CA$233.47m
- CA$278.53m
- CA$90.51m
- 75
- 92
- 73
- 94
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 63 | 22.2 | 77.4 | 32.5 | 90.5 |
Cost of Revenue | |||||
Gross Profit | 58.4 | 15.9 | 69.7 | 23.4 | 79.2 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 6.24 | 7.9 | 9.39 | 11 | 13.1 |
Operating Profit | 56.8 | 14.3 | 68 | 21.5 | 77.4 |
Net Income Before Taxes | 56.8 | 14.3 | 68 | 21.5 | 77.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 50.7 | 13.1 | 60 | 18.9 | 69.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 50.7 | 13.1 | 60 | 18.9 | 69.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 50.7 | 13.1 | 60 | 18.9 | 69.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.02 | 0.273 | 1.37 | 0.45 | 1.68 |
Dividends per Share |